Ranbaxy Laboratories Ltd (Merged)
Fortune 500 2014
+ 4 More
+ 4 More
Share
Share
OVERVIEW
FINANCIALS
NEWS
Featured In Fortune India Ranking
Fortune 500 India
#115(2014)
#86(2013)
#92(2012)
#80(2011)
#83(2010)
#115(2014)#86(2013)#92(2012)#80(2011)#83(2010)
Ranking Trend Fortune 500 India
Financial Data 2014
Revenue
13,739
(INR Cr)
Net Operating Income
13,268
(INR Cr)
Assets
10,525
(INR Cr)
Profit
-1,085
(INR Cr)
Net Worth
3,299
(INR Cr)
Fortune India Coverage
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 13739 8.7% | 12638 15.8% | 10911 5.2% | 10371 27.4% | 8140 3.6% | 7858 - |
| Net Operating Income (INR Cr) | 13268 6.49% | 12460 20.63% | 10329 16.29% | 8882 17.76% | 7542 2.84% | 7334 9.37% |
| Profit (INR Cr) | -1085 - | 923 - | -2900 - | 1497 404.8% | 296 - | -951 - |
| Assets (INR Cr) | 10525 1.0% | 10417 12.0% | 9298 -7.1% | 10004 24.6% | 8026 -7.2% | 8649 - |
| Net Worth (INR Cr) | 3299 -19.1% | 4079 42.5% | 2863 -48.9% | 5598 29.1% | 4336 1.4% | 4278 53.6% |
| Employee Cost (INR Cr) | 2577 33.7% | 1928 17.2% | 1645 10.1% | 1494 7.4% | 1391 12.7% | 1235 - |
| Interest Cost (INR Cr) | 557 | 304 | 306 | 61 | 71 | 206 |
| Cash & Bank Balance (INR Cr) | 1550 | 4600 | 3064 | 3264 | 1242 | 2396 |
| Total Debt (INR Cr) | 6598 | 4901 | 4491 | 4335 | 3630 | 4285 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|
| Profit As % Of Revenues | - | 7.3% | - | 14.4% | 3.6% | - |
| Profit As % Of Assets | - | 8.9% | - | 15.0% | 3.7% | - |
| Profit As % Of Networth | - | 22.6% | - | 26.7% | 6.8% | - |
| Interest Cost to EBITDA % | 512.1% | 19.2% | - | 4.5% | 10.8% | - |
| Debt to Equity Ratio | 2.00 | 1.20 | 1.57 | 0.77 | 0.84 | 1.00 |
| RONW | - | 28.4% | - | 26.7% | 7.0% | - |
| ROCE | 0.0% | 17.3% | 0.0% | 20.7% | 12.9% | 0.0% |